Figure 2
From: A retrospective analysis of pegylated liposomal doxorubicin in ovarian cancer: do we still need it?
Kaplan Meier overall survival: D-dimer and PLD treatment.
Figure 2 | Journal of Ovarian Research
From: A retrospective analysis of pegylated liposomal doxorubicin in ovarian cancer: do we still need it?
Kaplan Meier overall survival: D-dimer and PLD treatment.